{"id":47887,"date":"2023-04-24T14:40:19","date_gmt":"2023-04-24T09:10:19","guid":{"rendered":"http:\/\/finservwealth.com\/subscribe-to-mankind-pharma-geojit\/"},"modified":"2023-04-24T14:40:19","modified_gmt":"2023-04-24T09:10:19","slug":"subscribe-to-mankind-pharma-geojit","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/subscribe-to-mankind-pharma-geojit\/","title":{"rendered":"Subscribe to Mankind Pharma: Geojit"},"content":{"rendered":"<p> Geojit has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 21, 2023.<\/p><div id=\"finse-960530775\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-geojit_16969661.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Geojit has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 21, 2023. Geojit has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 21, 2023.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-geojit_16969661.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Geojit has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 21, 2023.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-geojit_16969661.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Geojit has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 21, 2023. Geojit has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 21, 2023.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-issues-open\/subscribe-to-mankind-pharma-geojit_16969661.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Geojit has come out with its report on Mankind Pharma. The research firm has recommended to \u00e2\u20ac\u0153 Subscribe \u00e2\u20ac\ufffd the ipo in its research report as on April 21, 2023.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-47887","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/I\/IPO1_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/47887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=47887"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/47887\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=47887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=47887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=47887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}